These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 21461431

  • 1. Studies on the photoactivation of two cytotoxic trans,trans,trans-diazidodiaminodihydroxo-Pt(IV) complexes.
    Westendorf AF, Bodtke A, Bednarski PJ.
    Dalton Trans; 2011 May 21; 40(19):5342-51. PubMed ID: 21461431
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA, Zabel M, Range KJ, Bednarski PJ.
    J Med Chem; 1996 Jun 21; 39(13):2499-507. PubMed ID: 8691447
    [Abstract] [Full Text] [Related]

  • 3. Photolysis of an iodoplatinum(IV) diamine complex to cytotoxic species by visible light.
    Kratochwil NA, Bednarski PJ, Mrozek H, Vogler A, Nagle JK.
    Anticancer Drug Des; 1996 Mar 21; 11(2):155-71. PubMed ID: 8630187
    [Abstract] [Full Text] [Related]

  • 4. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J, Liebeke M, Kaiser M, Bracht K, Olszewski U, Zeillinger R, Hamilton G, Braun D, Bednarski PJ.
    Anticancer Drugs; 2009 Aug 21; 20(7):559-72. PubMed ID: 19491657
    [Abstract] [Full Text] [Related]

  • 5. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S, Vastag L, Larrabee YC, Personick ML, Schaberg KB, Fowler BJ, Sandwick RK, Rawji G.
    Inorg Chem; 2008 Feb 18; 47(4):1352-60. PubMed ID: 18220340
    [Abstract] [Full Text] [Related]

  • 6. Effects of light-activated diazido-PtIV complexes on cancer cells in vitro.
    Bednarski PJ, Korpis K, Westendorf AF, Perfahl S, Grünert R.
    Philos Trans A Math Phys Eng Sci; 2013 Jul 28; 371(1995):20120118. PubMed ID: 23776289
    [Abstract] [Full Text] [Related]

  • 7. Influence of pyridine versus piperidine ligands on the chemical, DNA binding and cytotoxic properties of light activated trans,trans,trans-[Pt(N3)2(OH)2(NH3)(L)].
    Westendorf AF, Zerzankova L, Salassa L, Sadler PJ, Brabec V, Bednarski PJ.
    J Inorg Biochem; 2011 May 28; 105(5):652-62. PubMed ID: 21450268
    [Abstract] [Full Text] [Related]

  • 8. Effect of thioethers on DNA platination by trans-platinum complexes.
    Li C, Huang R, Ding Y, Sletten E, Arnesano F, Losacco M, Natile G, Liu Y.
    Inorg Chem; 2011 Sep 05; 50(17):8168-76. PubMed ID: 21812429
    [Abstract] [Full Text] [Related]

  • 9. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
    Ali MS, Khan SR, Ojima H, Guzman IY, Whitmire KH, Siddik ZH, Khokhar AR.
    J Inorg Biochem; 2005 Mar 05; 99(3):795-804. PubMed ID: 15708801
    [Abstract] [Full Text] [Related]

  • 10. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr 05; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

  • 11. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
    Farrell N, Kelland LR, Roberts JD, Van Beusichem M.
    Cancer Res; 1992 Sep 15; 52(18):5065-72. PubMed ID: 1516063
    [Abstract] [Full Text] [Related]

  • 12. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J, Villa MD, Cutillas N, López G, de Haro C, Bautista D, Moreno V, Valencia L.
    Inorg Chem; 2008 Jun 02; 47(11):4490-505. PubMed ID: 18447329
    [Abstract] [Full Text] [Related]

  • 13. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
    Zhao Y, Woods JA, Farrer NJ, Robinson KS, Pracharova J, Kasparkova J, Novakova O, Li H, Salassa L, Pizarro AM, Clarkson GJ, Song L, Brabec V, Sadler PJ.
    Chemistry; 2013 Jul 15; 19(29):9578-91. PubMed ID: 23733242
    [Abstract] [Full Text] [Related]

  • 14. The preparation and characterization of trans-platinum(IV) complexes with unusually high cytotoxicity.
    Cubo L, Hambley TW, Sanz Miguel PJ, Carnero A, Navarro-Ranninger C, Quiroga AG.
    Dalton Trans; 2011 Jan 14; 40(2):344-7. PubMed ID: 20936210
    [Abstract] [Full Text] [Related]

  • 15. Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs.
    Shi H, Romero-Canelón I, Hreusova M, Novakova O, Venkatesh V, Habtemariam A, Clarkson GJ, Song JI, Brabec V, Sadler PJ.
    Inorg Chem; 2018 Nov 19; 57(22):14409-14420. PubMed ID: 30365308
    [Abstract] [Full Text] [Related]

  • 16. A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin.
    Mackay FS, Woods JA, Moseley H, Ferguson J, Dawson A, Parsons S, Sadler PJ.
    Chemistry; 2006 Apr 03; 12(11):3155-61. PubMed ID: 16470886
    [Abstract] [Full Text] [Related]

  • 17. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J, Marini V, Najajreh Y, Gibson D, Brabec V.
    Biochemistry; 2003 May 27; 42(20):6321-32. PubMed ID: 12755637
    [Abstract] [Full Text] [Related]

  • 18. Photoactivatable platinum complexes.
    Bednarski PJ, Mackay FS, Sadler PJ.
    Anticancer Agents Med Chem; 2007 Jan 27; 7(1):75-93. PubMed ID: 17266506
    [Abstract] [Full Text] [Related]

  • 19. Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity.
    Griffith DM, Duff B, Suponitsky KY, Kavanagh K, Morgan MP, Egan D, Marmion CJ.
    J Inorg Biochem; 2011 Jun 27; 105(6):793-9. PubMed ID: 21497577
    [Abstract] [Full Text] [Related]

  • 20. Structure-activity relationship of new trans-platinum(II) and (IV) complexes with cyclohexylamine. Interference with cell cycle progression and induction of cell death.
    González-Vadillo AM, Alvarez-Valdés A, Moneo V, Blanco F, Díaz RG, Carnero A, Navarro-Ranninger C.
    J Inorg Biochem; 2007 Apr 27; 101(4):551-8. PubMed ID: 17257684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.